Zenith Drugs Wins Odisha Govt Tender Worth ₹9.5 Crore, Deepens Presence in Institutional Healthcare

Zenith Drugs Limited has notified the NSE that it has secured a key institutional order from Odisha State Medical Corporation Limited (OSMCL) under Regulation 30 of SEBI’s Listing Obligations and Disclosure Requirements. The award covers the supply of a wide basket of pharmaceutical formulations and allied products for state-run hospitals and health facilities across Odisha.​

The contract, with an approximate value of ₹9.50 crore and tenure of one year, is expected to contribute positively to the company’s topline during the contract period and strengthen its credentials in public health procurement programs. Zenith emphasised that the order has been received in the ordinary course of business and does not qualify as a related-party transaction.​

Key Highlights

Customer: Odisha State Medical Corporation Limited (OSMCL), Govt of Odisha undertaking.​

Nature of Order: Supply of pharmaceutical formulations (drugs and medical consumables).​

Indicative Products: Doxycycline capsules, salbutamol syrup, ferrous sulphate with folic acid syrup, metronidazole suspension, permethrin lotion, clotrimazole cream, povidone iodine solution, various ointments and other pharma products.​

Contract Duration: One year.​

Approximate Contract Value: ₹9.50 crore.​

Impact: Expected to support revenue growth and enhance standing in government and public healthcare procurement.​

Sources: Zenith Drugs Limited filing to NSE